Cargando…

Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology

The modeling of chimeric antigen receptor (CAR) T cell therapies has been mostly focused on immunodeficient models. However, there are many advantages in studying CAR-T cell biology in an immunocompetent setting. We generated a fully murine CAR targeting CD105 (endoglin), a component of the TGFβ rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lontos, Konstantinos, Wang, Yiyang, Colbert, Mason, Kumar, Alok, Joshi, Supriya, Philbin, Mary, Wang, Yupeng, Frisch, Andrew, Lohmueller, Jason, Rivadeneira, Dayana B., Delgoffe, Greg M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586682/ https://www.ncbi.nlm.nih.gov/pubmed/36275862 http://dx.doi.org/10.1080/2162402X.2022.2131229

Ejemplares similares

89723 CD105-targeted CAR T cells for the treatment of acute myeloid leukemia
por: Lontos, Konstantinos, et al.
Publicado: (2021)

Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors
por: Lontos, Konstantinos, et al.
Publicado: (2023)

IMMU-20. Effective CAR-T cell medulloblastoma therapy in an immunocompetent mouse model
por: Tsahouridis, Rania, et al.
Publicado: (2022)

Conditional Control of Universal CAR T Cells by Cleavable OFF-Switch Adaptors
por: Kvorjak, Michael, et al.
Publicado: (2023)

Conditional control of universal CAR T cells by cleavable OFF-switch adaptors
por: Kvorjak, Michael, et al.
Publicado: (2023)

Universal CARs, universal T cells, and universal CAR T cells
por: Zhao, Juanjuan, et al.
Publicado: (2018)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021)

PD-1 blocking strategy for enhancing the anti-tumor effect of CAR T cells targeted CD105
por: Wang, Xi, et al.
Publicado: (2023)

A bioengineered immunocompetent human leukemia chip for preclinical screening of CAR T cell immunotherapy
por: Ma, Chao, et al.
Publicado: (2023)

The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018)

CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
por: Arjomandnejad, Motahareh, et al.
Publicado: (2022)

mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting
por: Lohmueller, Jason J., et al.
Publicado: (2017)

Cable‐Car Electrocatalysis to Drive Fully Decoupled Water Splitting
por: Long, Yuanzheng, et al.
Publicado: (2023)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro
por: Liu, Maoxuan, et al.
Publicado: (2022)

CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy
por: Harrer, Dennis Christoph, et al.
Publicado: (2023)

Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia
por: Zhao, Juanjuan, et al.
Publicado: (2019)

CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV
por: Kim, Gloria B., et al.
Publicado: (2019)

Engineering CAR-T cells
por: Zhang, Cheng, et al.
Publicado: (2017)

CAR-T Cell Therapy
por: Ahmad, Aamir
Publicado: (2020)

Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells
por: Koristka, Stefanie, et al.
Publicado: (2019)

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
por: Martínez Bedoya, Darel, et al.
Publicado: (2021)

CAR T cell therapy becomes CHIC: “cytokine help intensified CAR” T cells
por: Thomas, Simone, et al.
Publicado: (2023)

Modeling interaction of Glioma cells and CAR T-cells considering multiple CAR T-cells bindings
por: Li, Runpeng, et al.
Publicado: (2023)

CAR models: next-generation CAR modifications for enhanced T-cell function
por: Abate-Daga, Daniel, et al.
Publicado: (2016)

CAR T Cells: A Snapshot on the Growing Options to Design a CAR
por: Holzinger, Astrid, et al.
Publicado: (2019)

Conventional CARs versus modular CARs
por: Feldmann, Anja, et al.
Publicado: (2019)

Potential lung attack and lethality generated by EpCAM-specific CAR-T cells in immunocompetent mouse models
por: Qin, Diyuan, et al.
Publicado: (2020)

The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
por: Herrera, Lara, et al.
Publicado: (2021)

Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
por: Albinger, Nawid, et al.
Publicado: (2021)

CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles’ Heel?
por: Ferreira, Leonardo M. R., et al.
Publicado: (2021)

Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion
por: Scharping, Nicole E., et al.
Publicado: (2021)

Seatbelts in CAR therapy: How Safe Are CARS?
por: Minagawa, Kentaro, et al.
Publicado: (2015)

Motor Cars for Doctors: Cars Suitable for Practitioners
Publicado: (1906)

CAR T Cell Therapy for Neuroblastoma
por: Richards, Rebecca M., et al.
Publicado: (2018)

CAR-T Cells: Future Perspectives
por: Charrot, Sarah, et al.
Publicado: (2019)

The making and function of CAR cells
por: Zabel, Maja, et al.
Publicado: (2019)

Improving CAR T-Cell Persistence
por: Pietrobon, Violena, et al.
Publicado: (2021)

In Situ Programming of CAR T Cells
por: Parayath, Neha N., et al.
Publicado: (2021)

Pharmacologic Control of CAR T Cells
por: Caulier, Benjamin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jg8mmun7usg1mpmeirh172thao